Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 Neoplasms 12 Colorectal Neoplasms 12 Pain 11 Pain, Postoperative 9 Prostatic Neoplasms 7 Lung Neoplasms 7 Agnosia 6 Colonic Neoplasms 5 Cancer Pain 5 Neuralgia 4 Keratosis, Actinic 4 Head and Neck Neoplasms 4 Liver Neoplasms 3 Leiomyoma 3 Chronic Pain 3 Thyroid Neoplasms 2 Stomatitis 2 Stomach Neoplasms 2 Recurrence 2 Pilonidal Sinus 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Myofibroma 2 Mucositis 2 Inflammatory Bowel Diseases 2 Ileus 2 Diverticulitis 2 Carcinoma, Non-Small-Cell Lung 2 Wounds and Injuries 1

Interventions

Tea 2 Bupivacaine 2 Tadalafil 1 Morphine 1 Lidocaine 1 Ketamine 1 Injections, Subcutaneous 1 Influenza Vaccines 1 Ethanol 1 Dexmedetomidine 1 Anesthetics, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Abdominal Cancer × Lidocaine × Clear all

NCT03063112 2017-02-28

RF

South Egypt Cancer Institute

Phase NA Unknown

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡